Botulinum toxin: State of the art

J Jankovic - Movement Disorders, 2017 - Wiley Online Library
Botulinun neurotoxin (BoNT) has emerged as one of the most multipurpose therapeutic
agents in modern medicine with more clinical applications than any other drug currently on …

[HTML][HTML] Novel botulinum neurotoxins: Exploring underneath the iceberg tip

DA Tehran, M Pirazzini - Toxins, 2018 - mdpi.com
Botulinum neurotoxins (BoNTs), the etiological agents of botulism, are the deadliest toxins
known to humans. Yet, thanks to their biological and toxicological features, BoNTs have …

Isolation and characterization of Hc-targeting chimeric heavy chain antibodies neutralizing botulinum neurotoxin type B

Y Jiang, R Wang, J Guo, K Cheng, L Chen… - Frontiers in …, 2024 - frontiersin.org
Background Botulinum neurotoxin (BoNT) produced by Clostridium botulinum is one of the
most potent known toxins. Moreover, BoNT is classified as one of the most important …

[HTML][HTML] A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype E subtypes

C Garcia-Rodriguez, A Razai, IN Geren, J Lou… - Toxins, 2018 - mdpi.com
Human botulism is most commonly caused by botulinum neurotoxin (BoNT) serotypes A, B,
and E. For this work, we sought to develop a human monoclonal antibody (mAb)-based …

[HTML][HTML] Clostridial neurotoxins: Structure, function and implications to other bacterial toxins

S Cai, R Kumar, BR Singh - Microorganisms, 2021 - mdpi.com
Gram-positive bacteria are ancient organisms. Many bacteria, including Gram-positive
bacteria, produce toxins to manipulate the host, leading to various diseases. While the …

Crystal structures of OrfX1, OrfX2 and the OrfX1–OrfX3 complex from the orfX gene cluster of botulinum neurotoxin E1

L Gao, K Lam, S Liu, A Przykopanski, J Lübke… - FEBS …, 2023 - Wiley Online Library
Botulinum neurotoxins (BoNTs) are among the most lethal toxins known to humans,
comprising seven established serotypes termed BoNT/A–G encoded in two types of gene …

[HTML][HTML] Variations in the botulinum neurotoxin binding domain and the potential for novel therapeutics

JR Davies, SM Liu, KR Acharya - Toxins, 2018 - mdpi.com
Botulinum neurotoxins (BoNTs) are categorised into immunologically distinct serotypes
BoNT/A to/G). Each serotype can also be further divided into subtypes based on differences …

Descriptive epidemiology of infant botulism in California: the first 40 years

MV Panditrao, HA Dabritz, NN Kazerouni… - The Journal of …, 2020 - Elsevier
Objective To ascertain the descriptive epidemiology of infant botulism, the flaccid paralysis
that results when neurotoxigenic Clostridium species produce botulinum toxin (BoNT) in the …

[HTML][HTML] The novel clostridial neurotoxin produced by strain IBCA10-7060 is immunologically equivalent to BoNT/HA

Y Fan, JR Barash, F Conrad, J Lou, C Tam, LW Cheng… - Toxins, 2019 - mdpi.com
Background: Botulinum neurotoxins (BoNTs) comprise seven agreed-on serotypes, A
through G. In 2014, a novel chimeric neurotoxin produced by clostridial strain IBCA10-7060 …

Substrate cleavage and duration of action of botulinum neurotoxin type FA (“H, HA”)

S Pellett, WH Tepp, G Lin, EA Johnson - Toxicon, 2018 - Elsevier
Botulinum neurotoxin (BoNT) type FA is the only known naturally occurring chimeric BoNT of
domains of BoNT/A and BoNT/F. BoNT/FA consists of an F5-like light chain (LC), a unique …